Page last updated: 2024-10-28

hexamethonium and Amaurosis

hexamethonium has been researched along with Amaurosis in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GOLDSMITH, AJ1
HEWER, AJ1
BRUCE, GM1

Other Studies

2 other studies available for hexamethonium and Amaurosis

ArticleYear
Unilateral amaurosis with partial recovery after using hexamethonium iodide.
    British medical journal, 1952, Oct-04, Volume: 2, Issue:4787

    Topics: Amblyopia; Blindness; Cardiovascular Agents; Hexamethonium; Muscle Relaxants, Central; Physiological

1952
Permanent bilateral blindness following the use of hexamethonium chloride.
    A.M.A. archives of ophthalmology, 1955, Volume: 54, Issue:3

    Topics: Blindness; Hexamethonium; Hypertension; Muscle Relaxants, Central; Vision Disorders

1955